Optimal timing for transcatheter device occlusion of a hemodynamically significant patent ductus arteriosus in preterm infants: evidence, uncertainty, and future directions
- 20 July 2026
- journal article
- perspective
- Published by Springer Nature in Journal of Perinatology
- p. 1-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Extreme Preterm Infant + PDA + PDA Management = OutcomeJAMA, 2026
- Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm InfantsJAMA, 2026
- Treatment of the Patent Ductus ArteriosusJAMA Pediatrics, 2025
- Active Treatment vs Expectant Management of Patent Ductus Arteriosus in Preterm InfantsJAMA Pediatrics, 2025
- Impact of PDA Closure Methodology on Peri-procedural Opioid Utilization in Preterm Neonates, a Cross-Sectional Review in a Tertiary Pediatric Healthcare SystemPediatric Cardiology, 2025
- Patent Ductus Arteriosus Morphology Changes in Preterm Neonates Undergoing Transcatheter Device ClosurePediatric Cardiology, 2025
- Device Closure of Hemodynamically Significant Patent Ductus Arteriosus in Premature InfantsJACC: Advances, 2024
- Safety and Short-Term Outcomes for Infants < 2.5 kg Undergoing PDA Device Closure: A C3PO Registry StudyPediatric Cardiology, 2023
- Early Role of the Atrial-Level Communication in Premature Infants with Patent Ductus ArteriosusJournal of the American Society of Echocardiography, 2020
- Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusionThe American Journal of Cardiology, 1989